Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments.

Shota OmoriKoji MuramatsuTakuya KawataEriko MiyawakiTaichi MiyawakiNobuaki MamesayaTakahisa KawamuraHaruki KobayashiKazuhisa NakashimaKazushige WakudaAkira OnoHirotsugu KenmotsuTateaki NaitoHaruyasu MurakamiTakashi SuginoToshiaki Takahashi

Published in: Journal of cancer research and clinical oncology (2021)

Although some anti-cancer treatments might alter the TROP2 expression, TROP2 was expressed in most lung cancer specimens before and after anti-cancer treatments. These results support the development of TROP2-directed therapy against advanced lung cancer in various treatment lines.

Keyphrases

poor prognosis
cell surface
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
binding protein
stem cells
bone marrow
combination therapy
replacement therapy
cell therapy
fine needle aspiration
chemotherapy induced